3rd Quarter - Report
SHIRE PHARMACEUTICALS LLC for SHIRE PHARMACEUTICALS LLC
Client
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 20, 2010 | $90,000 | Replaced |
| 3rd Quarter - Report (this page) | Jan 20, 2011 | $80,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to implementation of healthcare reform, ADHD awareness, orphan drugs and R&D funding, end stage renal disease bundling and non-injectable oral equivalents; reimbursements and comparative efffectiveness research
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOFF MASUKAWA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.